Recombinant Human Galectin-7/LGALS7 Protein
Sizes: 10ug, 50ug
Catalogue Number: RP02189-10, RP02189-50
Citations, Manuals and MSDS Available upon request.
Description: Recombinant Human Galectin-7/LGALS7 Protein is produced by E.coli expression system. The target protein is expressed with sequence (Met1-Phe136) of human LGALS7 (Accession #P47929).
Alternate Names: GAL7, LGALS7A, LGALS7
SWISS: P47929
GeneID: 3963
Species: Human
Purity: ≥ 95 % as determined by SDS-PAGE.
Storage: Store at -20℃. Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week.
Background: The Galectin family of proteins, with specificity for Nacetyllactosamine containing glycoproteins, consists of beta-galactoside binding lectins containing homologous carbohydrate recognition domains (CRDs).They also possess hemagglutination activity, which is attributable to their bivalent carbohydrate binding properties. Galectins are active both intracellularly and extracellularly. Although they are localized primarily in the cytoplasm and lack a classical signal peptide; they can be secreted by one or more as yet unidentified non-classical secretory pathways. They have diverse effects on many cellular functions including adhesion, migration, polarity, chemotaxis, proliferation, apoptosis, and differentiation. Galectins may play a key role in many pathological states, including autoimmune diseases, allergic reactions, inflammation, tumor cell metastasis, atherosclerosis, and diabetic complications.
Source: E. coli
Tag: No tag
Formulation: Lyophilized from a 0.2 μm filtered solution of 20mM Tris-HCl, 150mM NaCl, 1mM EDTA, 5% Trehalose, pH8.0.Contact us for customized product form or formulation.
Endotoxin: < 1 EU/μg of the protein by LAL method.
Research Use Only